Diagnostic utility of BAP1 and EZH2 expression in malignant mesothelioma. (Q40470064)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27859460%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

title

Diagnostic utility of BAP1 and EZH2 expression in malignant mesothelioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27859460%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27859460%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

author name string

Aya Shinozaki-Ushiku

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27859460%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Tetsuo Ushiku

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27859460%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Shigeki Morita

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27859460%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Masaki Anraku

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27859460%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Masashi Fukayama

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27859460%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

publication date

5 January 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27859460%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27859460%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27859460%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27859460%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

page(s)

722-733

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27859460%20AND%20SRC:MED&resulttype=core&format=json

New Markers for Separating Benign From Malignant Mesothelial Proliferations: Are We There Yet?

27 March 2020

cites work

1 reference

BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations.

21 January 2018

1 reference

Germline BAP1 mutations predispose to malignant mesothelioma

21 January 2018

1 reference

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

21 January 2018

1 reference

BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma.

21 January 2018

1 reference

Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology

21 January 2018

1 reference

BAP1 Immunostain and CDKN2A (p16) FISH Analysis: Clinical Applicability for the Diagnosis of Malignant Mesothelioma in Effusions.

21 January 2018

1 reference

The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma

21 January 2018

1 reference

BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of Sarcomatous and Desmoplastic Mesotheliomas.

21 January 2018

1 reference

Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens.

21 January 2018

1 reference

BAP1 protein is a progression factor in malignant pleural mesothelioma

21 January 2018

1 reference

High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma

21 January 2018

1 reference

Loss of expression of BAP1 predicts longer survival in mesothelioma

21 January 2018

1 reference

Loss of BAP1 function leads to EZH2-dependent transformation

21 January 2018

1 reference

21 January 2018

Targeting EZH2 in cancer

1 reference

FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma

21 January 2018

1 reference

Diagnostic usefulness of p16/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis.

21 January 2018

1 reference

Loss of expression of BAP1 is very rare in non-small cell lung carcinoma.

21 January 2018

1 reference

EZH2 promotes progression of small cell lung cancer by suppressing the TGF-β-Smad-ASCL1 pathway

21 January 2018

1 reference

Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HIS.13123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27859460%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

1 reference